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ABSTRACT
Group A streptococci (n = 123), isolated consecu-
tively from paediatric patients with pharyngitis
from Palermo, Italy, were analysed. The emm and
sof genes were sequenced, the presence of the
speA and speC genes was investigated, and the
macrolide resistance phenotypes and genotypes
were determined. A limited number of emm ⁄ sof
genotypes was found, and the most prevalent
types were different from those found in a
previous study from Rome. Macrolide resistance
was found in the most prevalent clones, suggest-
ing that the spread of mobile antibiotic resistance
genes among the ﬁttest clones in the community
was the main mechanism inﬂuencing macrolide
resistance rates in different emm types.
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Different rates of macrolide resistance have been
found in different clones of group A streptococci
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(GAS) [1–6]. Different clones of GAS can be
identiﬁed by sequencing the M-protein gene
(emm typing), and comparable results have been
obtained by emm typing and multilocus sequence
typing of GAS [7,8]. By sequencing the serum
opacity factor (sof) gene, emm types can be sub-
divided into sof+ and sof– isolates [9], with isolates
of GAS thus being assigned to ﬁve tissue-speciﬁc
adaptation groups corresponding to emm chromo-
somal patterns. Isolates with emm patterns A–C
are adapted to the upper respiratory tract; pattern
E isolates infect both the upper respiratory tract
and skin; and pattern D isolates are adapted to
skin infection. Isolates belonging to sof class I are
associated with pharyngitis and rheumatic fever,
while class II sof+ isolates are associated with both
pharyngeal and skin tropism [10].
With the use of emm and sof typing, it was
demonstrated previously that a limited number of
emm types were circulating among paediatric
patients with pharyngitis in Rome, and that
erythromycin-resistant isolates belonged to even
fewer emm types, as all except one were sof+
[3,4,11].
To verify these ﬁndings in a different Italian
community, 123 consecutive pharyngeal isolates
of GAS were collected from paediatric patients
with pharyngitis attending the Ospedale dei
Bambini of Palermo ambulatory and day care
centres between May 2001 and February 2002. The
isolates were emm-typed and the macrolide resist-
ance phenotypes and genotypes were determined
as described previously [3,4]. In order to further
characterise the clones into different pathogenic
groups, the presence of two toxin genes, speA and
speC [12–14], was investigated by PCR according
to established protocols [15].
Nineteen different emm sequence types were
found among the 123 isolates, with 13 emm types
displayed by multiple isolates. Most (80.5%)
isolates belonged to seven emm types (Table 1).
In Palermo, nine emm types contained more
than three isolates, accounting for 107 ⁄ 123
(87.0%) of the total isolates. In comparison, in
Rome, 13 emm types had more than three isolates,
accounting for 103 ⁄ 109 (94.49%) of the total
isolates [3,4].
In the present study, 77 isolates (62.6%; 13 emm
types) were sof+, compared to 72.5% in Rome. In
Palermo, 54.4% were pattern E sof+, 8.1% were
pattern A–C sof+, and 37.4% were pattern A–C
sof– (Table 1). In comparison, in Rome, 45.9%
were pattern E sof+, 25.7% were pattern A–C sof+,
and 26.6% were pattern A–C sof– [3]. Most
isolates (118 ⁄ 123; 95.9%) in Palermo were speA-
or speC-positive. Five isolates were negative for
both speA and speC. Twenty isolates were speA-
and speC-positive.
There were more macrolide-resistant isolates in
Palermo than in Rome (49.5% vs. 37.6%). Macro-
lide-resistant isolates belonged to nine different
emm types, and most (82.0%) were sof+ (compared
with 97.6% in Rome [4]). Macrolide-resistant
isolates in Palermo comprised 11 (23.9%) of 46
Table 1. Distribution of emm types, macrolide resistance genotypes and speA and speC genes in 123 consecutive paediatric
pharyngitis isolates of group A streptococci in Palermo, Italy, between May 2001 and February 2002
emm types Patterns erm(B) ⁄MLSB erm(B) ⁄ iMLSB mef(A) ⁄M erm(A) ⁄ iMLS Susceptible Total
speA+
speC–
speA–
speC+
speA+
speC+
speA–
speC–
emm75 ⁄ sof75 E 1 0 17 0 11 29 0 21 8 0
emm1 ⁄ sof– A–C 11 0 0 0 8 19 19 0 0 0
emm6 ⁄ sof– A–C 0 0 0 0 17 17 0 16 1 0
emm12 ⁄ sof12 A–C 0 0 9 0 1 10 0 8 1 1
emm22 ⁄ sof22 E 7 1 0 2 0 10 2 6 2 0
emm4 ⁄ sof4 E 0 0 6 0 1 7 0 6 1 0
emm5 ⁄ sof– A–C 0 0 0 0 7 7 0 6 1 0
emm77 ⁄ sof77 E 0 0 0 3 1 4 0 0 4 0
emm118 ⁄ sof118 E 2 0 0 0 2 4 0 4 0 0
emm44 ⁄ sof44 E 0 0 0 0 3 3 1 0 0 2
emm87 ⁄ sof87 E 0 0 0 0 3 3 0 2 0 1
emm9 ⁄ sof9 E 0 0 0 0 2 2 0 1 1 0
emm48 ⁄ sof48 E 0 0 0 0 2 2 0 2 0 0
emm11 ⁄ sof11 E 1 0 0 0 0 1 0 1 0 0
emm14 ⁄ sof– A–C 0 0 0 0 1 1 0 1 0 0
emm18 ⁄ sof– A–C 0 0 0 0 1 1 0 0 0 1
emm28 ⁄ sof28 E 0 0 0 0 1 1 0 1 0 0
emm29 ⁄ sof– A–C 0 0 0 0 1 1 1 0 0 0
emm89 ⁄ sof89 E 0 1 0 0 0 1 0 0 1 0
Total 22 2 32 5 62 123 23 75 20 5
MLSB, constitutive resistance to macrolides, lincosamide and streptogramin antibiotics; iMLSB, inducible resistance to macrolides, lincosamide and streptogramin antibiotics;
M, resistance to macrolides and sensitivity to lincosamide and streptogramin antibiotics; E, generalist (pharyngeal and skin) emm type; A–C, pharyngeal emm types.
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sof– pattern A–C isolates, and nine (90%) of ten
sof+ pattern A–C isolates, all of which belonged to
emm12 (Table 1). This latter type was also fre-
quent (64.3%) in Rome [4]. In addition, macro-
lide-resistant isolates accounted for 41 (61.2%) of
67 sof+ pattern E isolates. The most abundant emm
type in Palermo, emm75, was also represented
frequently among macrolide-resistant isolates (18
of 29 isolates), but accounted for only one isolate
in Rome. Among the 19 emm1 isolates, 11 were
macrolide-resistant (compared with 0 ⁄ 11 in
Rome).
Isolates that were sof– were less abundant than
sof+ isolates in both locations (37.4% in Palermo
vs. 25.4% in Rome). Among class E isolates,
54.5% were sof+ in Palermo, compared with
46.8% in Rome, while A–C sof+ (class II) isolates
were more abundant in Rome (25.7%, because of
28 emm12 isolates) than in Palermo (8.13%). Class
I A–C sof– isolates were more abundant in
Palermo because of 19 emm1 and 17 emm6 isolates
(11 and ﬁve, respectively, in Rome). Overall, with
the exception of the sof– emm1 type, the most
frequent emm types in the two locations were also
the most frequent macrolide-resistant emm types.
Based on the results of extensive surveillance
studies, macrolide resistance in isolates of GAS
from paediatric patients in Western countries is
found mainly in emm types that predominate
among circulating pharyngitis strains, which are
chieﬂy sof+ [1,14]. Gradual and rapid temporal
substitution of emm types has been described in
various communities [1,8,14,16,17]. However, in
communities with a greater prevalence of sof–
strains, e.g., military recruits [2], macrolide resist-
ance is more abundant in sof– types [2]. The
results of emm typing and tests for macrolide
susceptibility, and the presence of resistance and
virulence genes, indicate heterogeneity in some
emm types, e.g., emm22 and emm75. Thus, while
toxin proﬁles are highly conserved among the
most virulent emm types [14], virulence genes
may help to distinguish different groups among
clones. It may therefore be useful to examine
clones for the presence of a large number of toxin
genes [13,14].
Data for the genomes of GAS sequenced to date
indicate that they are poly-lysogenic [12]. Com-
plete or defective prophages code for virulence or
ﬁtness factors [12], and also for antibiotic resist-
ance genes. There is increasing evidence that
mobile DNA elements, particularly prophage or
chimeric structures, are responsible for the acqui-
sition of macrolide resistance by GAS. The mef(A)
genes have been found in Tn1207.3, which is a
conjugative transposon with a structure resem-
bling that of a phage [18], and in a 58.8-kb mobile
chimeric element [19]. The erm(A) gene has been
transferred in conjugation experiments from GAS
to other Gram-positive bacteria [20]. The above
data, together with the previous ﬁndings in Rome
[3,4], suggest that the prevalent circulating clones
of GAS are also those that acquire macrolide
resistance, probably following the spread of
mobile resistance elements among the most pre-
valent emm types in the community.
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ABSTRACT
A major outbreak of febrile syndrome occurred
during 2002 among the Greek Army forces in
Cyprus. Serological and molecular investigations
revealed that the causative agent was a Sicilian-
like phlebovirus. A virus strain was isolated from
a blood sample taken on the ﬁrst day of the
disease. Phylogenetic analysis of partial L RNA
segment sequences revealed that the strain from
Cyprus differed from sandﬂy Sicilian virus by
6.7% at the nucleotide level.
Keywords Cyprus, genetic detection, phlebovirus,
sandﬂy fever virus, virus isolation
Original Submission: 3 May 2005; Revised Submis-
sion: 6 June 2005; Accepted: 17 August 2005
Clin Microbiol Infect 2006; 12: 192–194
10.1111/j.1469-0691.2005.01330.x
Sandﬂy fever viruses (genus Phlebovirus, family
Bunyaviridae) are endemic among humans in
several regions of the world, including the
Mediterranean, Middle East, and northern
African and western Asian countries, where they
constitute a signiﬁcant health problem, especially
for foreign or non-native and non-immune visi-
tors [1]. They are responsible for a disease known
as sandﬂy fever, phlebotomus fever or Pappataci
fever. Interest in the disease increased during
World War II, as it incapacitated large numbers of
Allied and Axis soldiers serving in the Mediter-
ranean theatre of operations, especially USA
Army personnel. The disease was ﬁrst recognised
among American soldiers when the morbidity
rate of febrile cases increased during the period
they spent in North Africa (end of April 1943).
Study of the infected military personnel led to the
ﬁrst clinical description, the discovery of the
vector of the disease (Phlebotomus papatasii) and
the isolation of the responsible viruses, namely
sandﬂy fever Sicilian virus (SFSV) and sandﬂy
fever Naples virus (SFNV). [2].
Although the genus Phlebovirus consists cur-
rently of 68 distinct virus serotypes, eight sero-
types, namely Alenquer, Candiru, Chagres,
sandﬂy fever Naples, Punta Toro, Rift Valley
fever, SFSV and sandﬂy fever Toscana virus
(TOSV), have been linked to disease in humans
[3]. Seroepidemiological studies have shown that
the prevalence of antibodies against SFSV and
SFNV is > 50%, especially in Mediterranean
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